Back at the end of last year, Endonovo kicked off a
Back at the end of last year, Endonovo kicked off a preclinical investigation assessing the Immunotronics platform in a target indication of myocardial infarction (or heart attack, as it’s more commonly known). The idea is to treat patients with the technology after they have suffered a first heart attack, with the goal of strengthening their cardiac muscle tissue and – in turn – reducing their chances of a second heart attack or complete heart failure (which is a remarkably common outcome in this patient population). At the trial’s initiation, the company reported that it expected to have data with shareholders by the end of the first quarter of this year. Fast forward a few months, and alongside a release detailing a fresh patent issue for the technology, management amended its target data release date to early second quarter 2017. The numbers haven’t hit press yet and we expect them to hit any day now. Why is this such a big deal? The implications of these numbers go beyond the myocardial infarction indication. The best way to look at his trial is as a sort of proof of concept study. If the company can prove that its technology has a regenerative impact on heart muscle tissue cells, there’s no real reason why it won’t have a similar impact on cells in other regions of the body.
Management just recently reported the initiation of two further preclinical studies, one in NASH and another in critical limb ischemia, and we see this as positive for the treatment’s chances of good MI data.
Why?
Well, it’s speculative, but why would a company kick off an expanded program if the proof of concept looked like it was failing? Chances are that management likes what it is seeing in the MI study and that it’s getting a jump on some expanded indications ahead of putting out the numbers.
1 Billion plus market cap on the horizon for ENDV.
Endonovo Therapeutics, Inc. (ENDV) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Sun Home's Black Friday Warm-Up If ever there was a time to crank up the heat on a deal, it’s right now. Sun Home Saunas, a San Diego stalwart in the home wellness space, launched their Black Friday blitz today, offering savings that's hotter than a summer day in Death Valley. Between November 6 and December 7, they're slashing prices left and right, tossing in free...
Continue Reading
In the hustle and bustle of manufacturing, EPG Modular Data Center has hit a landmark moment. They're not just slapping up another building—they're carving out a piece of future tech infrastructure with their fresh Malaysia FIZ Factory. Investing in Regional Strength When you pump US$120 million into a project, you're doing more than sinking cash into concrete—you're...
Continue Reading
An Unconventional Legacy: South Park’s Journey There's a new kind of 'heritage' on display at the Colorado History Museum that's bound to shake a few eyebrows in December 2026. More than just cutouts and characters, South Park: Handmade in Colorado delves into the crazy, outrageous journey of Trey Parker and Matt Stone's brainchild from its humble beginnings to a...
Continue Reading
Leaving Old Lab Notebooks in the Dust Deep Principle just shook up the science lab with their latest brainchild, Hydrogen-1.0. We're talking about an AI-driven marvel designed to tackle chemistry and materials research like no traditional lab rat ever could. On November 4, they rolled out this bad boy—an open-weight model fine-tuned to turn vague scientific hunches into...
Continue Reading
Recognition in Radiation Oncology In the rapidly advancing arena of radiation oncology, staying current is no small feat. But here's a feather in the cap of one publication doing just that: Fundamentals of Radiation Oncology: Physical, Biological, and Clinical Aspects, 4th Edition. This resource has made quite the splash by snagging a spot on the 2026 Doody's Core Titles...
Continue Reading
David Coleman: Vaudit's New Ad Chief David Coleman stepping into Vaudit's spotlight as President of Advertising Industry is a twist worth watching. Vaudit, for those not up to speed, is an AI-driven powerhouse that keeps vendors in line with what they're charging. And let me tell you, Coleman's kind of heavy-hitter leadership doesn't come cheap, nor does it play nice with...
Continue Reading
Workday: A Force in the Cloud ERP Arena Right on! Workday's making waves again in the world of Cloud ERP. In a move that seems to defy the competition, they've locked down their spot as a Leader in the 2026 Gartner Magic Quadrant for Cloud ERP for Service-Centric Enterprises for the fifth year running. Consistency isn’t a coincidence here, folks—this is pure strategy!...
Continue Reading
Stock Market Whiplash: UP Fintech's Rough Ride You know, just when you think you've seen it all in this bonkers stock market world, something like a 25% drop in UP Fintech’s stock reminds you that surprises never end. Now, UP Fintech’s facing a class action lawsuit, alleging it didn’t exactly play fair, sparking this latest rollercoaster ride. Yeah, buckle up folks,...
Continue Reading
Fresh Faces Navigate a Storied Institution In this unpredictable dance of leadership, the Boston Society of Architects (BSA) just laid its cards on the table for 2027. The latest board of directors and governance committees were announced with the kind of precision that shows how serious these folks are about preparing for a future that's anything but predictable. Handing...
Continue Reading
Ondo Finance Claims Tokenization Throne Damn, if you thought tokenization was just a sideshow in the fintech carnival, think again. Ondo Finance has waltzed its way to the front of the line, claiming the heavyweight title with over $4 billion in tokenized real-world assets. That's right, folks—$4 billion in the bag, handily surpassing 202 other platforms with its...
Continue Reading
Top 5 Most Recently Viewed Articles
CentralReach Makes Strides in Autism and IDD Care CentralReach, a prominent provider of autism and intellectual and developmental disabilities (IDD) care software, has recently secured a Gold award in the esteemed Healthcare Technology Solution category at the 23rd Annual American Business Awards. This recognition acknowledges the company's exceptional Autism and IDD Care...
Continue Reading
Kaneka Expands Horizons with EndoStream Medical Acquisition In a significant move to enhance its product offerings, Kaneka Corporation has officially announced the acquisition of a substantial stake in EndoStream Medical Ltd., an innovative Israeli medical equipment developer. The acquisition of 96.8% of shares aims to synergize Kaneka's robust manufacturing capabilities...
Continue Reading
Current Market Sentiment for 3M Co 3M Co (NYSE: MMM) has seen a notable increase in short interest as a percentage of its float, rising by 8.7% since the last report. With approximately 7.95 million shares sold short, this accounts for about 1.5% of the total available shares for trading. Based on recent trading activity, it is estimated that on average, it would take...
Continue Reading
Meta's Launch of Smart Glasses Recently, Meta Platforms, Inc. (NASDAQ: META) celebrated the launch of its new smart glasses, priced at $799, alongside a sprightly demonstration by their CEO, Mark Zuckerberg. These innovative glasses feature a built-in display that promises to enhance the user's experience remarkably. Smart Glasses Overview These smart glasses, initially...
Continue Reading
Important Update on Annual Meeting Materials Current Water Technologies Inc. (TSX-V: WATR) has recently announced a significant update regarding the materials for its upcoming annual general meeting. Due to an ongoing postal strike in Canada, there will be delays in receiving these crucial documents by shareholders. This situation is unfortunate but highlights the...
Continue Reading